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Abstract
Background: Integrated Management of Childhood Illness (IMCI) is a WHO/UNICEF strategy to
improve child survival in resource poor settings. South Africa adopted IMCI in 1997, and IMCI
guidelines were adapted to include identification and management of HIV infected and exposed
children. This study describes the validity of the IMCI/HIV algorithm when used by IMCI experts,
the use of IMCI/HIV guidelines by IMCI trained health workers in routine clinical practice, and the
burden of HIV among children under 5 years attending first level health facilities.
Methods: Seventy seven randomly selected IMCI trained health workers were observed in 74
health facilities in two provinces of South Africa. Consultations were observed with 1357 sick
children; each child was reassessed by an IMCI expert to confirm the correct findings. Consent was
requested for HIV testing of all children who attended with a parent or legal guardian. Positive rapid
HIV tests were confirmed with HIV PCR in children aged less than 18 months. HIV positive children
had a CD4 count and HIV clinical staging done.
Results: Of 1064 children with HIV results available, 76 (7.1% CI: 5.7% - 8.9%) children were
confirmed HIV positive. IMCI experts using the HIV algorithm classified 54/76 (71.1% CI: 59.5%-
80.9%) HIV positive children as suspected symptomatic HIV, and 15/22 remaining HIV positive
children were identified as HIV exposed. Therefore, 69/76 (90.8% CI: 81.9-96.2) HIV infected
children were identified by IMCI experts. No classification was made for HIV by observed health
workers in 899/1357(66.2%) children.
906/1243(72.9%) mothers had been tested previously for HIV, of whom 221(24.4%) reported
testing positive. Of 221 children therefore identified as HIV exposed, only 78(35.3%) had been
tested for HIV within routine services.
Conclusion: The HIV algorithm is a valid tool for identifying HIV infected and exposed children
when correctly and comprehensively implemented. However, it is not being used by IMCI trained
health workers in routine practise, leading to a failure to implement life saving interventions.
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Background
South Africa is among those countries worst affected by
the HIV epidemic. In 2006, HIV sero-prevalence among
pregnant women attending government antenatal clinics
was 29.1% [1], and paediatric HIV disease has led to a
reversal of the gains that had been achieved in reducing
child mortality [2]. Despite the introduction of a pro-
gramme for prevention of mother to child transmission of
HIV (PMTCT) in South Africa, vertical transmission rates
of 20.8% have been reported [3], and inadequate testing
and follow-up of HIV exposed children is found in
PMTCT programmes across the region [4,5]. Mortality
among HIV infected children is high; over 50% of
untreated African children die in the first 2 years of life [6].
Identification of HIV infected children and early initiation
of antiretroviral treatment (ART) would substantially
improve mortality [7], but despite availability of free ART,
only a minority of children needing treatment receive it
[8]. New guidelines from the World Health Organization
(WHO) recommend that where virological testing is una-
vailable, ART should be initiated in children based on
clinical diagnosis alone, and the HIV status confirmed as
soon as possible [9]. It is, therefore, urgent that strategies
are implemented to improve follow-up of HIV exposed
children, increase early identification of children with
symptomatic HIV, and improve access to ART for chil-
dren.
Integrated management of childhood illness (IMCI) is a
WHO/UNICEF strategy to improve child survival in
resource poor settings [10], and South Africa is one of 43
African countries to adopt IMCI as the standard of care for
children at primary level [11]. IMCI guidelines were
adapted to include a validated HIV component to identify
and manage HIV infected and exposed children. Accord-
ing to these guidelines, every mother bringing a sick child
to a health facility is asked whether she has had an HIV
test, and if she reports having tested HIV positive, the
child is identified as HIV exposed. All children should also
be routinely checked for common signs and symptoms
found to be most predictive of HIV infection [12]. If three
signs are present, the child is classified as suspected sympto-
matic HIV and the carer advised that the child should have
an HIV test. These two components make up the HIV algo-
rithm (figure 1), and IMCI includes guidelines for man-
agement of HIV infected and exposed children. The HIV/
IMCI algorithm has been shown to be a valid tool for
identification of children with symptomatic HIV infection
[12], and may have a role in identifying those HIV
exposed children most at risk of early death [13].
First level health workers are trained to use the IMCI/HIV
guidelines during the 11-day IMCI case management
course [14], a structured training course supported by
comprehensive training materials developed by WHO/
UNICEF, and adapted for use in South Africa. Training
materials relating to the HIV component were added, and
participants learn the practical skills required during clin-
ical sessions, but the overall duration of the training
course was not increased. The IMCI/HIV algorithm pro-
vides a clear guideline for health workers to identify chil-
dren for whom HIV testing is indicated, and its effective
implementation is an important entry point to care at pri-
mary level for HIV infected and exposed children and
their families in South Africa, and other high prevalence
countries [15].
Previous reviews of IMCI implementation have shown
that IMCI training improves health worker performance
[16], but implementation of the HIV guidelines has not
been evaluated previously. We conducted this study to
determine how the IMCI/HIV guidelines are used by IMCI
trained health workers, the validity of the HIV algorithm
when used by expert IMCI practitioners and in routine
clinical practice, as well as the burden of HIV disease
among children under 5 years attending first level health
facilities.
Methods
Study site and population
IMCI trained health workers working in first level health
facilities in Limpopo and in Kwazulu-Natal (KZN) prov-
inces, South Africa, were included in this study. IMCI
training has been ongoing in both provinces since 1998,
and at the time of the study 1325 health workers had been
trained in Limpopo Province and 1300 in KZN. Limpopo
province has a population of 5.5 million, and is predom-
inantly rural, with high rates of poverty and poor access to
basic services[17]. KZN has lower rates of poverty and sev-
eral large urban centres, but almost 50% of the popula-
tion still live in rural areas. With a population of 10
million, KZN is the most populous of South Africa's prov-
inces [18]. Antenatal HIV sero-prevalence in 2006 was
39.1% and 21.5% in KZN and Limpopo respectively [1].
In order to evaluate routine IMCI implementation, all
IMCI trained health workers currently working in a pri-
mary health care (PHC) clinics were eligible to participate.
PHC clinics provide first level care to communities and
this care is provided mainly by nurses. The district hospi-
tal provides support and referral care to PHC clinics in the
surrounding area. Study participants were selected by a
simple random sample, using computer generated ran-
dom numbers http://www.random.org, from a list of all
IMCI trained health workers working in PHC clinics in
each of the two provinces. All observed health workers
had attended an 11-day IMCI training course, which
included the HIV component. All first level health workers
were informed by the Department of Health that a survey
of child health practices was to be undertaken, butBMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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observed health workers were not told beforehand that
they had been selected, or that IMCI in particular was
being evaluated.
Training and Data Collection
Data collection teams consisting of two expert IMCI prac-
titioners and two study counsellors, trained in HIV coun-
selling, were identified for each province. All IMCI experts
were experienced IMCI facilitators. Data collection teams
were trained by the investigators (CH, KV) for two weeks;
this included a refresher of the IMCI/HIV guidelines (the-
ory and clinical sessions) and training on HIV transmis-
sion, HIV testing, WHO clinical staging [19], and data
collection, including storage and handling of blood sam-
ples. A pilot study was conducted in two health facilities,
and data collection tools were adapted accordingly.
All sick children aged from 2 months up to 5 years attend-
ing the health facility were eligible to participate; consent
was requested from carers by study counsellors (figure 2).
The consultation by the health worker was observed by an
IMCI expert, who recorded the activities and findings
without intervening. The same observer was used for all
observations of a particular health worker. Thereafter, a
second IMCI expert assessed the same child separately and
recorded the findings, which were considered the gold
standard for analysis of health worker performance. The
second IMCI expert was blinded to the findings of the
observed health worker. If an IMCI expert was known to
the health worker then, if possible, that expert undertook
re-assessments of observed children, and did not observe
the health worker. No identifying information was
recorded about observed health workers or PHC clinics
visited. If the management of the child was incorrect, this
was changed by the second IMCI expert to ensure all chil-
dren received appropriate treatment. Each health worker
was observed for up to 20 consultations with sick children
presenting consecutively to the health facility, or for three
days, whichever was shorter.
Current version of the HIV Algorithm, last updated in 2003 Figure 1
Current version of the HIV Algorithm, last updated in 2003.BMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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Flow of study participants through data collection process Figure 2
Flow of study participants through data collection process.
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Data collection tools
Standardized data collection instruments were used to
record the data. Interviews were conducted with health
workers to find out about their training in child health,
including IMCI. Resources available at the clinic were
observed and recorded using a checklist; these included
essential medicines and equipment, HIV counselling and
testing supplies and services, numbers of children rou-
tinely tested for HIV, and whether privacy was available
for consultations with children.
Observations were conducted using a standardized check-
list based on the IMCI consultation; activities undertaken
during the consultation were recorded, including whether
relevant history and examination was undertaken, and
whether appropriate counselling messages were given to
the mother. On completion of the consultation, the
observer reviewed the child's card and recorded all IMCI
classifications made by the health worker. At no time did
the observer interfere in the consultation; feedback was
given to the health worker only when all observed consul-
tations were complete. The findings of the IMCI expert
who re-assessed the child were recorded on a standard
IMCI recording form, which is widely used during train-
ing to record IMCI findings.
Teams were visited regularly by the principal investigator,
and all completed questionnaires were checked to moni-
tor quality during data collection.
Consent and ethical approval
Written informed consent was obtained from the carer by
the study counsellor in the local language. Consent was
requested for observation of the consultation, a second
assessment of the child by an IMCI expert, and for HIV
counselling and testing of the child. If the carer was not
the legal guardian, consent was requested for observation
only. If consent was obtained for HIV testing, pre- and
post-test counselling was performed by study counsellors.
If the child was known to be HIV infected, and this could
be confirmed from the medical record, this was recorded
without repeating the HIV test.
This study was conducted in partnership with the South
African Department of Health and health workers selected
were required to participate.
Each child was assigned a study number at enrolment; no
names were recorded in the database, and results of HIV
tests were linked to clinical data only after completion of
the study. Ethical approval was obtained from the Bio-
medical Research Ethics Committees of the University of
KwaZulu-Natal Medical School, Durban, and WHO,
Geneva.
HIV testing
Children over 18 months of age were screened for HIV
antibodies using the rapid test Determine™ HIV-1/2
(Abbott, Weisbaden, Germany). All positives were con-
firmed by a second HIV rapid test using the Smart Check™
HIV1/2 (World Diagnostics Inc, Miami, USA). In children
aged below 18 months, if the screening HIV rapid test was
positive, 50 l of whole blood was collected by heel prick
using a lancet, and dropped onto a filter paper for the
dried blood spot (DBS). The filter paper was transported
to Inkosi Albert Luthuli Central Hospital (IALCH) in Dur-
ban for PCR testing. The dried blood spots were tested for
HIV-1 DNA using the HIV-1 DNA test, version 1.5 (Roche,
Branchburg, USA). All children confirmed as HIV infected
had 1-2 ml of blood taken in an EDTA tube (Vacuette,
GreinerBio-one, Kremsumunster, Austria) which was sent
to IALCH for CD-4 cell count; this was performed using
the Panleucogated CD4 Epics® XL™ (Beckmancoulter, Gal-
way, Ireland). All blood samples were discarded when
HIV testing was complete.
Children under 18 months who could not have their HIV
status confirmed immediately had post-test counselling
and CD4 testing done by study staff at a follow-up visit.
All HIV positive children were started on co-trimoxazole
prophylaxis, and assessed for initiation of ART.
Sample Size
The estimated sensitivity of the IMCI/HIV algorithm when
used by IMCI trained health workers compared to IMCI
experts was used to calculate the sample size. Based on
assumptions that 80% of observed children would be cor-
rectly classified for HIV with 10% precision at 95% confi-
dence levels, it was calculated that 62 children classified as
suspected symptomatic HIV by the expert IMCI practitioners
should be sampled.
Health workers were observed for up to 20 consultations
to increase the likelihood that every health worker would
see at least one case of suspected symptomatic HIV. This was
based on 2005 antenatal HIV sero-prevalence of 19.3% in
the lower prevalence setting of Limpopo [20], and the
assumption that one third of children born to HIV
infected women become infected, so community preva-
lence was estimated to be 6.5% for the purpose of sample
size calculation.
As the study progressed, it was evident that many health
workers were not using the IMCI/HIV guidelines, and an
interim analysis was conducted. The sensitivity of the
health worker using the HIV algorithm, compared to the
IMCI expert was only 26% at the mid-point of the study.
Furthermore, the community prevalence in Limpopo was
only 2.0%. The sample size was, therefore, recalculatedBMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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and an additional 15 IMCI trained health workers ran-
domly selected in KZN.
Data management and analysis
Pre-coded data were double entered, cleaned and vali-
dated using Epi-info (version 6.04). Analysis was con-
ducted using SPSS (version 13.0) and Stata (version 9.0).
To determine the performance of the health workers,
assessments by the health worker were compared to those
of the IMCI expert, which were considered to be the gold
standard for this purpose. To determine the validity of the
HIV algorithm compared to the HIV test results, sensitiv-
ity, specificity, positive and negative predictive values, and
likelihood ratios were calculated.
Results
Consultations of 77 IMCI trained health workers, in 74
primary level health facilities in KZN and Limpopo prov-
inces, were observed between May 2006 and January
2007. Consent was obtained to observe 1357 consulta-
tions (figure 3), and each health worker was observed for
a mean of 2.7 days (SD 0.68) and 17.7 consultations (SD
4.8). The average age of observed children was 19.6
months (SD 15.0), and 552 (40.7%) were under the age
of one year. A total of 499 consultations were observed in
Limpopo and 858 in KZN.
Training and supervision of observed health workers
All observed health workers were nurses, and the average
time since IMCI training was 32.2 months (SD 18.4; range
3-88 months). The HIV algorithm was updated in 2003 to
its current version (figure1); 19/77 (24.7%) health work-
ers had been trained on a previous version, of whom 8/19
(42.1%) had received specific training on the updated ver-
sion. All observed health workers were using the current
version of the IMCI guidelines.
Of the 77 observed health workers, 55 (71.4%) had no
training related to child health, other than IMCI training.
One health worker had been trained as an IMCI supervi-
sor and one as an IMCI facilitator; 7 had a diploma in pri-
mary health care, which includes a paediatric module;
and 4 had attended a short course related to paediatric
care, including tuberculosis (1), antiretroviral treatment
(1) and immunization (2). Training in HIV/AIDS coun-
selling had been completed by 66/77 (85.7%) health
workers.
It is recommended that new IMCI practitioners receive a
follow-up visit 4-6 weeks after training to assist in transfer-
ring their skills to the workplace; 51 (66.2%) health work-
ers had a follow-up visit by an IMCI supervisor since being
trained, of these, 13 (25.5%) had received two visits and
3 (5.9%) three visits. There was no regular, ongoing IMCI
supervision.
Facility supports for IMCI/HIV guidelines
Children were seen in a private area at 50 of 74 (67.6%)
health facilities visited. Co-trimoxazole was available in
71 (95.9%) clinics and nevirapine syrup in 58(78.4%).
Although 39 (52.7%) clinics reported being able to do
HIV PCR tests on children, only 24 (32.4%) had done any
PCR tests in the past month, and 32 (41.6%) clinics had
not tested any child under 5 years for HIV in the past
month.
HIV results
HIV results were available for 1064 children; 1060 chil-
dren tested during the study and 10 children reported HIV
positive, less 6 children whose results were lost (figure 3).
Of these, 76 children were found to be HIV positive, so
that HIV prevalence among children attending primary
health care clinics was 76/1064 (7.1% CI: 5.7% - 8.9%).
Mother's reported HIV status
Among 1243 children who attended the clinic with their
parent or legal guardian, 906 (72.9%) mothers were
reported to have had an HIV test, and 221 (24.4%) were
reported as having tested HIV positive. 221 children were,
therefore, identified as HIV exposed, of whom 78 (35.3%)
had been tested for HIV by routine services.
Among mothers of the 76 HIV positive children, 62
reported having had an HIV test, of whom 43 reported
having a positive test, 17 reported testing negative, and 2
did not know the result.
Indications for anti-retroviral treatment
Of the 76 children confirmed HIV positive, one child was
currently on ART. A CD4 count was performed by the
study team on 40/75 of the remaining HIV positive chil-
dren. ART was considered to be indicated in children with
a CD4%<20% and those who were WHO stage 3 or 4.
When a CD4 result was unavailable, indication for ART
was determined by WHO clinical staging alone. ART was
indicated in 63/75 (84.0%) HIV infected children (table
1).
Performance of the HIV algorithm used by the IMCI expert 
compared to HIV test
Of 1064 children with an HIV test result available, 171
(16.1%) children were classified as suspected symptomatic
HIV by the IMCI expert; 54 (71.1%) of whom were HIV
positive (table 2). Of 22 HIV infected children with insuf-
ficient signs for a classification of suspected symptomatic
HIV, 15 were identified as HIV exposed. So, when the HIV
algorithm was fully implemented according to the exist-
ing IMCI guideline (figure 2), 69/76 (90.8%) HIV infected
children were identified as either suspected symptomatic
HIV or HIV exposed (table 2). Of 63 HIV infected childrenBMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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Outcome of HIV testing for all study participants Figure 3
Outcome of HIV testing for all study participants.
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where ART was considered to be indicated, 52 (82.5%)
were classified as suspected symptomatic HIV (table 1).
Use of the HIV guidelines by IMCI trained health workers 
compared to IMCI expert
Many health workers (31/77; 40.3%) did not classify for
HIV in any child, and 9 did not classify any child correctly
for HIV. Although 3/77 health workers did classify for HIV
in every child, no health worker classified every child cor-
rectly for HIV.
Health workers made a classification for symptomatic
HIV in 428/1357 (31.5%) children; of these 342 (25.2%)
were classified correctly as compared to the IMCI expert.
Table 1: Performance of the HIV algorithm in identifying those children where antiretroviral treatment (ART) is indicated
ART indicated
(n = 76)
Number %
(95% CI)
Number Identified by algorithma Proportion identified by 
algorithm % (95% CI)
Indicated by CD4<20% 22 8.9
(19.0 - 41.2)
18 81.8
(59.4 - 93.3)
Indicated by WHO clinical stage 3 or 4 60 78.9
(67.4 - 87.2)
50 83.3
(70.0 - 91.5)
Total ART indicated 63 82.9
(71.2 - 90.5)
52 82.5
(69.4-90.8)
ART not indicated by CD4 count or 
clinical staging
61
ART not indicated by clinical staging, 
CD4 not available
61
Already on ART 1 0
Total 76 54 71.1
(59.5 - 80.4)
a classified as suspected symptomatic HIV
Table 2: Performance of the HIV algorithm compared to HIV test results
n = 1064a Classified as suspected 
symptomatic HIV
Identified as HIV exposed Any HIV classification (either HIV 
exposed OR suspected symptomatic 
HIV)
# 171 201 313
# confirmed HIV positive 54 43 69
Sensitivity
(95% CI)
71.1%
(59.5% - 80.9%)
56.6%
(44.7% - 67.9%)
90.8%
(81.9% - 96.2%)
Specificity
(95% CI)
88.1%
(85.9% - 90.1%)
84.0%
(81.6% - 86.2%)
75.3%
(72.5% - 77.9%)
PPV
(95% CI)
31.6%
(24.7% - 39.15)
21.4%
(15.9% - 27.7%)
22.0%
(17.6% - 27.1%)
NPV
(95% CI)
97.5%
(96.3% - 98.4%)
96.2%
(94.7% - 97.4%)
99.1%
(98.1% - 99.6%)
Likelihood ratio +
(95% CI)
5.99
(4.79 - 7.48)
3.54
(2.77 - 4.51)
3.67
(3.22 - 4.18)
a comprises all children where an HIV test result is knownBMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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Among all observed children, 202 (14.9%) were classified
as suspected symptomatic HIV by the IMCI expert; of these
37 (18.3%) were correctly classified by the health worker.
Health workers classified 84 children as suspected sympto-
matic HIV, including 28/76 (36.8% CI: 24.7% - 51.0%)
HIV infected children. Health workers correctly identified
161/223 (72.6% CI: 65.3% - 79.3%) children classified as
HIV exposed by the IMCI expert. It was not possible to
determine the sensitivity and specificity of the HIV algo-
rithm when used by the health worker compared to the
HIV test, because 68.5% children were not classified for
HIV.
Health workers management of suspected symptomatic 
HIV
Of 84 children classified as suspected symptomatic HIV by
the health worker, 54(64.3%) carers were advised of the
need for HIV testing, co-trimoxazole prophylaxis was pre-
scribed for 26 (31.0%) children, and feeding advice was
given to carers of 36 (43.0%) children.
Discussion
This study shows that when the HIV algorithm is applied
to all children by skilled IMCI practitioners it is an effec-
tive tool to identify HIV infected children, and its imple-
mentation could improve access to life saving treatments
for HIV infected and exposed children. However, the HIV
component of IMCI is frequently not implemented by
IMCI trained health workers in routine clinical practice;
few children classified as suspected symptomatic HIV by
IMCI experts were correctly classified by health workers,
and most children were not classified for HIV at all. Even
when health workers made the classification of suspected
symptomatic HIV, children were not tested for HIV and
essential treatments were not initiated.
There are several possible reasons for poor implementa-
tion of HIV guidelines in our setting, IMCI training may
not give health workers adequate skills, and some health
workers were trained using a previous version of the HIV
algorithm. HIV related stigma may make health workers
reluctant to mention HIV during a consultation with a
child [21], although the high uptake of HIV testing among
our study participants suggests that most mothers want
information about their child's HIV status. The low posi-
tive predictive value (PPV) of the HIV algorithm may also
negatively affect implementation. It is important that
health workers understand that the HIV algorithm is a
screening tool, not a diagnostic test, and that most chil-
dren identified by the HIV algorithm will test HIV nega-
tive. This should be clearly explained during IMCI
training, and health workers trained in the appropriate
counselling messages to give to a mother when advising
her to take her child for HIV testing. If health workers do
not understand that such children will frequently test HIV
negative and expect this outcome, they may lose confi-
dence in the algorithm and be reluctant to use it. Simi-
larly, if mothers who are advised to take their child for
HIV testing do not get clear and appropriate messages, it
may make routine checks for HIV in children unaccepta-
ble to communities.
Poor implementation of the HIV component may also be
an aspect of poor implementation of IMCI overall.
Although IMCI implementation has been shown to
improve health worker performance [16,22], poor adher-
ence to the guideline has been previously reported
[23,24]. Reasons suggested for this include heavy work-
loads [25], additional time needed for an IMCI consulta-
tion [26], and lack of clinical supervision and support.
Supportive supervision of IMCI trained health workers
has been found to contribute to improvements in correct
treatment and counselling [23], but our findings show
that many IMCI trained health workers had not received a
supervisory visit, and there was no ongoing IMCI supervi-
sion.
Poor implementation of the PMTCT program is also high-
lighted; despite many mothers reporting a positive HIV
test, most HIV exposed children had not been tested, and
many clinics were not testing any children under 5 years.
Strengthening of PMTCT and its linkage with IMCI is
required, together with improved access to HIV PCR test-
ing for HIV exposed children. Comprehensive PMTCT
implementation and early confirmation of HIV status of
all exposed children may reduce the need for an algorithm
to identify symptomatic HIV, but it will still have a role for
children whose mothers do not disclose their status, and
those whose mothers become infected during pregnancy
and breastfeeding. In settings where virological testing is
not readily available, the algorithm may play an impor-
tant role in clinical decision making [13].
Despite poor implementation, we have shown that when
the HIV algorithm is comprehensively applied to all chil-
dren by skilled IMCI practitioners, a high proportion of
HIV infected children are identified, confirming the find-
ings of a previous validation study [12]. The HIV algo-
rithm is an effective screening tool, and performs better in
children where ART is indicated. However, although the
sensitivity of the algorithm is above 90%, even in this
high prevalence population the PPV is low, and would be
even lower in a low HIV prevalence setting. In our popu-
lation of children almost one third were identified as
requiring an HIV test, and it is important to recognise that
this represents a significant burden on the health system.
No previous studies have reported HIV prevalence and the
burden of HIV disease among children under 5 in this set-BMC Pediatrics 2009, 9:59 http://www.biomedcentral.com/1471-2431/9/59
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ting; our study shows that undiagnosed HIV infection is
common in PHC clinics, and most of these children have
advanced disease. Early initiation of ART improves mor-
tality [7], and recommendations now suggest that ART
should be initiated in children under 1 year as soon as the
HIV status is confirmed [9]. Our findings strongly support
the IMCI recommendation to check all children for possi-
ble HIV infection.
The strengths of this study include that the IMCI experts
were all experienced IMCI facilitators, and able to provide
a reliable gold standard. We were able to observe larger
numbers of children and health workers than previous
health facility surveys [23,27,28], and could, therefore,
describe performance with the health worker as the unit of
analysis. We were also able to test most enrolled children
for HIV, and measure outcomes confidently. Health work-
ers were not given notice of the study team's arrival, a large
number of observations over several days reduced subject
bias, and data collection tools were designed to minimise
interaction between health worker and observer and
reduce the chance of performance improving over time.
Limitations of the study include: the observer's presence
may have influenced health worker performance, some
health workers may have 'learned' what was required dur-
ing the observation period, and some IMCI experts and
health workers may have known each other, all of which
could have led to bias. In order to avoid interfering during
the consultation, we did not evaluate health workers' per-
formance in identifying specific signs, and because of
poor implementation we were not able to determine the
performance of the HIV algorithm in routine practise. In
addition, the sensitivity of HIV rapid tests in children
under 18 months has not been fully evaluated, and we
were not able to obtain CD4 results for all HIV infected
children.
Conclusion
In conclusion, IMCI has a potential to identify HIV
infected and exposed children using the existing guide-
lines and to provide more and earlier access to care for
many children. However, poor IMCI implementation is
severely limiting this in routine practice. Further investiga-
tion is required to determine the reasons for poor health
worker performance, and to provide evidence-based inter-
ventions to address poor IMCI implementation. Possible
interventions could include strengthening IMCI training,
IMCI updates to help maintain skills, as well as increased
support and supervision. There is a high burden of HIV
disease in PHC clinics and it is critical that these children
access treatment if child mortality is to be reduced in
South Africa.
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